Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Liquidia Technologies Inc (LQDA)

Liquidia Technologies Inc (LQDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 72,576
  • Shares Outstanding, K 18,657
  • Annual Sales, $ 2,710 K
  • Annual Income, $ -53,140 K
  • 60-Month Beta 0.52
  • Price/Sales 28.05
  • Price/Cash Flow N/A
  • Price/Book 3.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.62
  • Number of Estimates 2
  • High Estimate -0.53
  • Low Estimate -0.71
  • Prior Year -0.62
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.37 +16.62%
on 11/21/19
4.37 -10.07%
on 11/29/19
+0.34 (+9.47%)
since 11/08/19
3-Month
3.36 +16.96%
on 11/08/19
5.31 -25.99%
on 10/29/19
-0.22 (-5.30%)
since 09/10/19
52-Week
3.25 +20.92%
on 09/03/19
27.44 -85.68%
on 12/26/18
-18.39 (-82.39%)
since 12/10/18

Most Recent Stories

More News
Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Misses Revenue Estimates

Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of -38.46% and -100.00%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for...

LQDA : 3.93 (+1.03%)
Liquidia Technologies Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Completed Registrational Studies of LIQ861 to Include in New Drug Application (NDA)

LQDA : 3.93 (+1.03%)
Liquidia Technologies, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Liquidia Technologies, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on November 13, 2019 at...

LQDA : 3.93 (+1.03%)
Liquidia to Report Third Quarter 2019 Financial Results and Provide Corporate Update on November 13, 2019

Liquidia Technologies, Inc. (Nasdaq: LQDA) ("Liquidia" or the "Company"), a late-stage clinical biopharmaceutical company, today announced that third quarter 2019 financial results will be reported on...

LQDA : 3.93 (+1.03%)
Liquidia Technologies Appoints Industry Veteran Katie Rielly-Gauvin to Board of Directors

Liquidia Technologies, Inc. (Nasdaq: LQDA) ("Liquidia" or the "Company"), a late-stage clinical biopharmaceutical company, today announced the appointment of Katie Rielly-Gauvin, Vice President of Global...

LQDA : 3.93 (+1.03%)
Liquidia to Present at Cantor 2019 Global Healthcare Conference

Liquidia Technologies, Inc. (Nasdaq: LQDA) ("Liquidia" or the "Company"), a late-stage clinical biopharmaceutical company, announced that Neal Fowler, Chief Executive Officer of Liquidia, will present...

LQDA : 3.93 (+1.03%)
Liquidia Technologies Appoints Industry Veteran Dr. Joanna Horobin to Board of Directors

Liquidia Technologies, Inc. (Nasdaq: LQDA) ("Liquidia" or the "Company"), a late-stage clinical biopharmaceutical company, today announced the appointment of Joanna Horobin, M.B., Ch.B., to the Company's...

LQDA : 3.93 (+1.03%)
Liquidia to Present at H.C. Wainwright Healthcare Conference

Liquidia Technologies, Inc. (Nasdaq: LQDA) ("Liquidia" or the "Company"), a late-stage clinical biopharmaceutical company, announced that Neal Fowler, Chief Executive Officer of Liquidia, will present...

LQDA : 3.93 (+1.03%)
Liquidia to Present at Wedbush PacGrow Healthcare Conference

Liquidia Technologies, Inc. (Nasdaq: LQDA) ("Liquidia" or the "Company"), a late-stage clinical biopharmaceutical company, announced that Neal Fowler, Chief Executive Officer of Liquidia, will present...

LQDA : 3.93 (+1.03%)
Liquidia Technologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update

On Track for Planned New Drug Application (NDA) Submission for LIQ861 in Late 2019

LQDA : 3.93 (+1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade LQDA with:

Business Summary

Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of...

See More

Key Turning Points

2nd Resistance Point 4.29
1st Resistance Point 4.11
Last Price 3.93
1st Support Level 3.65
2nd Support Level 3.37

See More

52-Week High 27.44
Fibonacci 61.8% 18.20
Fibonacci 50% 15.35
Fibonacci 38.2% 12.49
Last Price 3.93
52-Week Low 3.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar